✦ LIBER ✦

TCT-203: No Difference In Long-term Major Adverse Cardiac Event Rates Between Paclitaxel-eluting and Sirolimus-eluting Stents

Book ID: 119270986
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 231 KB
Volume: 58
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2011.10.207

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of sirolimus-eluting stent an

Comparison of sirolimus-eluting stent and paclitaxel-eluting stent for long-term cardiac adverse events in diabetic patients: The Korean multicenter angioplasty team (KOMATE) registry

✍ Jung-Sun Kim; Byoung Ho Lee; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Pil-Ki M 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

## Abstract Background: There is some controversy on long‐term cardiac outcomes between sirolimus‐eluting stents (SES) and paclitaxel‐eluting stents (PES) in diabetes mellitus (DM). We compared cardiac adverse events after SES and PES implantation in patients with DM over a period of 3 year. Method

Comparison of efficacy between paclitaxe

Comparison of efficacy between paclitaxel-eluting stents with different polymers in terms of major adverse cardiac events and stent thrombosis up to 12 months of clinical follow-up

✍ Soon Yong Suh; Kyoung Hoon Lee; Jeonggeun Moon; Woong Chol Kang; Seung Hwan Han; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 125 KB